1.67
price down icon5.65%   -0.10
after-market アフターアワーズ: 1.64 -0.03 -1.80%
loading
前日終値:
$1.77
開ける:
$1.71
24時間の取引高:
151.38K
Relative Volume:
0.16
時価総額:
$77.94M
収益:
-
当期純損益:
$-82.60M
株価収益率:
-0.8107
EPS:
-2.06
ネットキャッシュフロー:
$-48.61M
1週間 パフォーマンス:
-11.64%
1か月 パフォーマンス:
-23.74%
6か月 パフォーマンス:
-50.88%
1年 パフォーマンス:
-48.62%
1日の値動き範囲:
Value
$1.67
$1.77
1週間の範囲:
Value
$1.65
$1.92
52週間の値動き範囲:
Value
$1.49
$6.06

Vigil Neuroscience Inc Stock (VIGL) Company Profile

Name
名前
Vigil Neuroscience Inc
Name
セクター
Healthcare (1177)
Name
電話
857-254-4445
Name
住所
100 FORGE ROAD, WATERTOWN
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
VIGL's Discussions on Twitter

VIGL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
VIGL
Vigil Neuroscience Inc
1.67 77.94M 0 -82.60M -48.61M -2.06
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Vigil Neuroscience Inc Stock (VIGL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-04 開始されました William Blair Outperform
2023-12-19 ダウングレード Morgan Stanley Equal-Weight → Underweight
2023-10-18 開始されました JMP Securities Mkt Outperform
2023-03-31 開始されました Mizuho Buy
2022-09-16 開始されました Wedbush Outperform
2022-08-29 開始されました H.C. Wainwright Buy
2022-02-01 開始されました Guggenheim Buy
2022-02-01 開始されました Jefferies Buy
2022-02-01 開始されました Morgan Stanley Equal-Weight
2022-02-01 開始されました Stifel Buy
すべてを表示

Vigil Neuroscience Inc (VIGL) 最新ニュース

pulisher
Apr 02, 2025

Vigil Neuroscience Presents Data on its Small Molecule - GlobeNewswire

Apr 02, 2025
pulisher
Apr 02, 2025

Vigil Neuroscience advances Alzheimer’s drug into Phase 2 trials By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

Vigil Neuroscience advances Alzheimer’s drug into Phase 2 trials - Investing.com India

Apr 02, 2025
pulisher
Apr 02, 2025

Vigil presents data on oral small molecule program including VG-3927 - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Clinical Data Breakthrough: Vigil's New Alzheimer's Drug Targets Both Aβ and Tau Pathologies - Stock Titan

Apr 02, 2025
pulisher
Apr 02, 2025

Vigil Neuroscience Reports 2024 Results and Clinical Progress - TipRanks

Apr 02, 2025
pulisher
Mar 31, 2025

Vigil Neuroscience Files Secondary Stock Shelf - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

Vigil Neuroscience, Inc. (NASDAQ:VIGL) Sees Large Decline in Short Interest - Defense World

Mar 31, 2025
pulisher
Mar 18, 2025

Vigil Neuroscience (VIGL) to Release Earnings on Tuesday - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

H.C. Wainwright cuts Vigil Neuroscience stock target to $14 By Investing.com - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

Vigil Neuroscience (VIGL) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Mar 17, 2025
pulisher
Mar 17, 2025

H.C. Wainwright cuts Vigil Neuroscience stock target to $14 - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

FY2029 Earnings Forecast for VIGL Issued By Wedbush - Defense World

Mar 17, 2025
pulisher
Mar 17, 2025

Q1 Earnings Estimate for VIGL Issued By William Blair - Defense World

Mar 17, 2025
pulisher
Mar 16, 2025

HC Wainwright Has Lowered Expectations for Vigil Neuroscience (NASDAQ:VIGL) Stock Price - Defense World

Mar 16, 2025
pulisher
Mar 16, 2025

Wedbush Has Lowered Expectations for Vigil Neuroscience (NASDAQ:VIGL) Stock Price - Defense World

Mar 16, 2025
pulisher
Mar 14, 2025

Vigil Neuroscience Inc.: Promising Biomarker Data and Strategic Advancements Justify Buy Rating - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

Wedbush Cuts Price Target on Vigil Neuroscience to $13 From $24, Keeps Outperform Rating - Marketscreener.com

Mar 14, 2025
pulisher
Mar 14, 2025

Stifel maintains Buy on Vigil Neuroscience, target at $11 By Investing.com - Investing.com Australia

Mar 14, 2025
pulisher
Mar 14, 2025

Vigil Neuroscience Faces Market Risks from Preferred Stock Issuance and Potential Share Dilution - TipRanks

Mar 14, 2025
pulisher
Mar 13, 2025

Vigil Neuroscience stock surges 10% on positive Alzheimer’s drug data By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

Vigil Neuroscience stock surges 10% on positive Alzheimer’s drug data - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Stifel maintains Buy on Vigil Neuroscience, target at $11 - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Vigil Neuroscience, Inc. SEC 10-K Report - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

Vigil Neuroscience, Inc. Reports Positive Phase 1 Data for VG-3927 and Outlines Upcoming Milestones in Alzheimer’s Disease and ALSP Treatment Programs - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Vigil Neuroscience, Inc. Loss At -$23.83 Mln In Q4 - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Vigil Neuroscience Reports Fourth Quarter and Full Year - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Vigil's Alzheimer's Drug Shows 50% Brain Biomarker Reduction in Phase 1 Success - StockTitan

Mar 13, 2025
pulisher
Mar 13, 2025

SPY ETF News, 3/13/2025 - The Globe and Mail

Mar 13, 2025
pulisher
Mar 11, 2025

Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

Vigil Neuroscience To Present At The Stifel 2025 Virtual CNS Forum - MENAFN.COM

Mar 11, 2025
pulisher
Mar 11, 2025

Exclusive CNS Forum: Vigil Neuroscience Reveals Latest Breakthroughs in Neurodegeneration Treatment - StockTitan

Mar 11, 2025
pulisher
Mar 06, 2025

Will Vigil Neuroscience (NASDAQ:VIGL) Spend Its Cash Wisely? - Yahoo Finance

Mar 06, 2025
pulisher
Mar 05, 2025

Best Stock to Buy Right Now: Dutch Bros vs. Starbucks - The Globe and Mail

Mar 05, 2025
pulisher
Mar 04, 2025

Short Interest in Vigil Neuroscience, Inc. (NASDAQ:VIGL) Drops By 43.6% - Defense World

Mar 04, 2025
pulisher
Mar 01, 2025

Why Vigil Neuroscience, Inc. (VIGL) is Skyrocketing So Far in 2025 - Insider Monkey

Mar 01, 2025
pulisher
Feb 20, 2025

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL) - PR Newswire

Feb 20, 2025
pulisher
Feb 17, 2025

What Did We Find About Insider Trading At Vigil Neuroscience Inc (NASDAQ: VIGL)? - Stocks Register

Feb 17, 2025
pulisher
Feb 16, 2025

Vigil Neuroscience advances Alzheimer's drug to Phase 2 trial - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Short Interest in Vigil Neuroscience, Inc. (NASDAQ:VIGL) Increases By 145.8% - MarketBeat

Feb 16, 2025
pulisher
Feb 14, 2025

abrdn plc Purchases 293,461 Shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL) - MarketBeat

Feb 14, 2025
pulisher
Feb 09, 2025

VIGLVigil Neuroscience, Inc. Latest Stock News & Market Updates - StockTitan

Feb 09, 2025
pulisher
Feb 06, 2025

VIGL Stock Update: Vigil Neuroscience Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle

Feb 06, 2025
pulisher
Feb 05, 2025

The Attractiveness of Investing In Vigil Neuroscience Inc (VIGL) is Growing - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Are Vigil Neuroscience Inc’shares a good deal? - US Post News

Feb 05, 2025
pulisher
Jan 30, 2025

Vigil Neuroscience to Present at Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire

Jan 30, 2025
pulisher
Jan 30, 2025

Neurodegenerative Disease Pioneer Vigil to Reveal Latest Developments at Major Biotech Conference - StockTitan

Jan 30, 2025
pulisher
Jan 27, 2025

Vigil Neuroscience Reports Positive Data from Phase 1 Clinical Trial on Potential Alzheimer’s Treatment - Defense World

Jan 27, 2025

Vigil Neuroscience Inc (VIGL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
大文字化:     |  ボリューム (24 時間):